Ann: MND Biomarkers and Pharmacodynamics Results, page-171

Agree kicking Goals,,just no score on the board to show for it....NZT

Come on Drysa , the Company is worth less today than when the MND Trial Begun?? now with confirmation of Solubility , Tolerability, MND Patients are able to easily swallow them.. plus the actual Tablet has been developed and refined and passed stability testing ..

Reduced Critical Proteins in Urine and Biomarkers indicating stasis of disease.. Has to be worth at least a 1 cent rise?

K9 life expectancy increased by over a year with a massive increase in the QOL,, that surely has commercial Value? Yesterday that gained a Pip?

I Understand your position , you have unbridled faith in Managements ability ,, I see they are lacking a single discipline , Thats why they hired Anusha?

Management lack Marketing Skills ,, the result of this lack of skill set is clearly why the SP is exactly where it is...Because it's not the results MPL is delivering...

Best of Luck with your investment , I hope at some stage this train leaves the station... for all investors,,, Increased SP and Scientific Progress on hundreds of Bio's go hand in hand,, they are not mutually exclusive by any stretch...

If the Oppies aren't struck then PAA have enough in the Kitty till end of December to Mid January... and you don't want to be doing another CR with a 20% discount from down here at 8 cents...